Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences. - Aix-Marseille Université Access content directly
Journal Articles Thrombosis Research Year : 2016

Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences.

Abstract

The primary hemostatic function of platelets has been recognized for more than a century, but increasing experimental and clinical evidences suggest that platelets are also important mediators of cancer. Cancer indeed influences platelet physiology, and activated platelets participate in each step of cancer development by promoting tumor growth, angiogenesis, metastasis, and cancer-associated thrombosis. Based on both the results of numerous experimental models addressing the involvement of platelets in cancer progression and the results of epidemiologic studies on the use of anti-platelet drugs to prevent cancer, platelets have been proposed as a potential target to reduce the short-term risk of cancer, cancer dissemination and cancer mortality. However, the cancer-associated thrombosis and the risk of bleeding due to anti-platelet drugs are not enough evaluated in experimental models. Therefore, the interesting contribution of platelets to cancer and cancer-associated thrombosis requires the standardization of preclinical and clinical models.
Fichier principal
Vignette du fichier
mezouar2016.pdf (684.38 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01455290 , version 1 (13-02-2020)

Identifiers

Cite

Soraya Mezouar, Corinne Frère, Roxane Darbousset, Diane Mege, Lydie Crescence, et al.. Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences.. Thrombosis Research, 2016, 139, pp.65-76. ⟨10.1016/j.thromres.2016.01.006⟩. ⟨hal-01455290⟩

Collections

UNIV-AMU ANR FRM
373 View
1485 Download

Altmetric

Share

Gmail Facebook X LinkedIn More